@article{f113cd7b252945b3aca6ebd322747d9a,
title = "Tarlatamab: the promising immunotherapy on its way from the lab to the clinic",
keywords = "Tarlatamab, bispecific T cell engager (BiTE), immunotherapy, lung cancer",
author = "Daolin Tang and Rui Kang",
note = "Funding Information: uniform disclosure form (available at https://tlcr.amegroups. com/article/view/10.21037/tlcr-23-115/coif). Research by DT and RK was supported by grants from the National Institutes of Health (Nos. R01CA160417, R01CA229275, and R01CA211070).",
year = "2023",
month = jun,
day = "30",
doi = "10.21037/tlcr-23-115",
language = "English (US)",
volume = "12",
pages = "1335--1357",
journal = "Translational Lung Cancer Research",
issn = "2218-6751",
publisher = "Society for Translational Medicine (STM)",
number = "6",
}